Analyst Ratings For AstraZeneca plc (LON:AZN)
Today, Barclays PLC reiterated its Overweight rating on AstraZeneca plc (LON:AZN) with a price target of GBX 5,500.
There are 3 sell ratings, 9 hold ratings, 8 buy ratings on the stock.
The current consensus rating on AstraZeneca plc (LON:AZN) is Hold (Score: 2.25) with a consensus target price of GBX 5,041.80 per share, a potential .
Some recent analyst ratings include
- 8/1/2017-Barclays PLC Reiterated Rating of Overweight.
- 7/28/2017-Morgan Stanley was Downgraded by analysts at Morgan Stanley from a “Equal Weight” rating to a “” rating. They now have a GBX 4,700 price target on the stock, up previously from GBX 5,600 .
- 7/28/2017-Beaufort Securities was Downgraded by analysts at Beaufort Securities from a “Sell” rating to a “” rating. They now have a GBX 3,900 price target on the stock.
- 7/28/2017-J P Morgan Chase & Co Reiterated Rating of Neutral.
- 7/28/2017-Citigroup Inc. Reiterated Rating of Buy.
Recent Trading Activity for AstraZeneca plc (LON:AZN)
Shares of AstraZeneca plc closed the previous trading session at 4,540.00 down -29.00 -0.63% with 4,251,800 shares trading hands.
